» Articles » PMID: 28735441

Pathology of Neuroendocrine Tumours of the Female Genital Tract

Overview
Journal Curr Oncol Rep
Publisher Current Science
Specialty Oncology
Date 2017 Jul 24
PMID 28735441
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Neuroendocrine tumours are uncommon or rare at all sites in the female genital tract. The 2014 World Health Organisation (WHO) Classification of neuroendocrine tumours of the endometrium, cervix, vagina and vulva has been updated with adoption of the terms low-grade neuroendocrine tumour and high-grade neuroendocrine carcinoma. In the endometrium and cervix, high-grade neoplasms are much more prevalent than low-grade and are more common in the cervix than the corpus. In the ovary, low-grade tumours are more common than high-grade carcinomas and the term carcinoid tumour is still used in WHO 2014. The term ovarian small-cell carcinoma of pulmonary type is included in WHO 2014 for a tumour which in other organs is termed high small-cell neuroendocrine carcinoma. Neuroendocrine tumours at various sites within the female genital tract often occur in association with other neoplasms and more uncommonly in pure form.

Citing Articles

Carcinoid tumor arising from a mature cystic teratoma of the ovary: A case report.

Huang W, Han X, Zhou J, Zhang G Medicine (Baltimore). 2025; 104(7):e41557.

PMID: 39960926 PMC: 11835118. DOI: 10.1097/MD.0000000000041557.


Mixed Trabecular and Mucinous Carcinoid Arising in the Background of a Mature Ovarian Cystic Teratoma.

Ali S, Khan H, Malik A, Ali S, Hussain A Cureus. 2025; 17(1):e77013.

PMID: 39912039 PMC: 11798423. DOI: 10.7759/cureus.77013.


Cervical Neuroendocrine Carcinoma Presenting as Isolated Large Ovarian Metastasis: A Case Report.

Faridzi A, Ariani Sugianto G, Gumilar K, Tjokroprawiro B Am J Case Rep. 2025; 26():e945078.

PMID: 39819883 PMC: 11751734. DOI: 10.12659/AJCR.945078.


Clinicopathologic feature and treatment progress of high-grade ovarian neuroendocrine tumors.

He Q, Wang C, Huang D, Shen J, Liu R, Guan Y Med Oncol. 2024; 42(1):2.

PMID: 39541042 DOI: 10.1007/s12032-024-02544-w.


Clinicopathological and epigenetic differences between primary neuroendocrine tumors and neuroendocrine metastases in the ovary.

Mulders M, Verschuur A, de Lussanet de la Sabloniere Q, Roes E, Geisenberger C, Brosens L J Pathol Clin Res. 2024; 10(6):e70000.

PMID: 39513463 PMC: 11544441. DOI: 10.1002/2056-4538.70000.


References
1.
Ikota H, Kaneko K, Takahashi S, Kawarai M, Tanaka Y, Yokoo H . Malignant transformation of ovarian mature cystic teratoma with a predominant pulmonary type small cell carcinoma component. Pathol Int. 2012; 62(4):276-80. DOI: 10.1111/j.1440-1827.2012.02804.x. View

2.
Agaimy A, Erlenbach-Wunsch K, Konukiewitz B, Schmitt A, Rieker R, Vieth M . ISL1 expression is not restricted to pancreatic well-differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic origin. Mod Pathol. 2013; 26(7):995-1003. DOI: 10.1038/modpathol.2013.40. View

3.
Robboy S, Scully R . Strumal carcinoid of the ovary: an analysis of 50 cases of a distinctive tumor composed of thyroid tissue and carcinoid. Cancer. 1980; 46(9):2019-34. DOI: 10.1002/1097-0142(19801101)46:9<2019::aid-cncr2820460921>3.0.co;2-w. View

4.
Rindi G, Kloppel G, Alhman H, Caplin M, Couvelard A, de Herder W . TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006; 449(4):395-401. PMC: 1888719. DOI: 10.1007/s00428-006-0250-1. View

5.
Plockinger U, Wiedenmann B . Treatment of gastroenteropancreatic neuroendocrine tumors. Virchows Arch. 2007; 451 Suppl 1:S71-80. DOI: 10.1007/s00428-007-0446-z. View